Search | Clinical Trials Finder

Conditions: Myofascial Trigger Point Pain, Myofacial Pain
Interventions: Trigger point injection with 1% lidocaine, Lidocaine patch 5%; Procedure · Drug
Lead sponsor: University of California, Irvine; Other
Eligibility: 18 Years and older
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Orange, California

Conditions: Vulvodynia
Interventions: CO2 laser, Lidocaine patch 5%; Device · Drug
Lead sponsor: Atlantic Health System; Other
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Denville, New Jersey

Conditions: Chronic Low Back Pain
Interventions: Lidoderm®, Celecoxib; Drug
Lead sponsor: Endo USA Inc., a Keenova Therapeutics Company; Industry
Eligibility: 18 Years and older
Enrollment: 98 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2004
U.S. locations: 21
States / cities: Northport, Alabama • Phoenix, Arizona • Beverly Hills, California + 18 more

Conditions: Healthy
Interventions: Lidocaine patch 1.8%, Lidocaine patch 5%, Lidocaine medicated plaster 5%; Drug
Lead sponsor: Scilex Pharmaceuticals, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 47 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017
U.S. locations: 1
States / cities: Fair Lawn, New Jersey

Conditions: Postherpetic Neuralgia, Diabetic Neuropathy, Complex Regional Pain Syndrome, Carpal Tunnel Syndrome, HIV Neuropathy, Idiopathic Sensory Neuropathy, Peripheral Neuropathy
Interventions: Placebo Capsules + Placebo Patch, Placebo capsules + Lidoderm®, Gabapentin + Placebo, Gabapentin + Lidoderm®, Gabapentin 300 mg capsules 1800 mg/day + placebo patch, Gabapentin 1800 mg/day + Lidoderm patch; Drug
Lead sponsor: Endo USA Inc., a Keenova Therapeutics Company; Industry
Eligibility: 18 Years and older
Enrollment: 62 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2003
U.S. locations: 7
States / cities: Birmingham, Alabama • Hueytown, Alabama • Phoenix, Arizona + 4 more

Conditions: Adhesive Capsulitis of the Shoulder, Frozen Shoulder
Interventions: Hormone Replacement Therapy (HRT), Corticosteroid and 1%lidocain, physical therapy; Drug · Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 40 Years and older · Female only
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Chronic Low Back Pain
Interventions: Lidoderm®; Drug
Lead sponsor: Endo USA Inc., a Keenova Therapeutics Company; Industry
Eligibility: 18 Years and older
Enrollment: 102 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2003
U.S. locations: 6
States / cities: Birmingham, Alabama • Hueytown, Alabama • Phoenix, Arizona + 3 more

Conditions: Painful Diabetic Neuropathy (PDN), Diabetic Nephropathies
Interventions: Cognitive Behavioral Therapy (CBT), Oral Medication, Topical Medication; Device · Drug
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years and older
Enrollment: 600 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2031
U.S. locations: 23
States / cities: Stanford, California • Jacksonville, Florida • Chicago, Illinois + 17 more

Conditions: Pain, Postoperative
Interventions: Lidoderm 5 % Topical Patch, Sham Topical Patch; Drug · Other
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 18 Years to 89 Years · Female only
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Healthy
Interventions: Lidocaine 5% patch, Lidocaine hydrochloride, Lidoderm 5% patch; Drug
Lead sponsor: Nicole K Brogden; Other
Eligibility: 18 Years to 65 Years
Enrollment: 23 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Tinnitus
Interventions: Transdermal Lidocaine; Drug
Lead sponsor: University of California, Davis; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Healthy
Interventions: lidocaine topical system 1.8%, lidocaine patch 5%; Drug
Lead sponsor: Scilex Pharmaceuticals, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018
U.S. locations: 1
States / cities: Dilworth, Minnesota

Conditions: Osteoarthritis of the Knee
Interventions: Lidoderm, Celecoxib; Drug
Lead sponsor: Endo USA Inc., a Keenova Therapeutics Company; Industry
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004
U.S. locations: 20
States / cities: Hueytown, Alabama • Mesa, Arizona • Oro Valley, Arizona + 17 more

Conditions: Osteoarthritis Nos, of Sacroiliac Joint
Interventions: Cooled RFA of sacral lateral branches; Procedure
Lead sponsor: Milton S. Hershey Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2022
U.S. locations: 1
States / cities: Hershey, Pennsylvania

Conditions: Sacroiliac Joint Complex, Low Back Pain
Interventions: Nimbus Sacroiliac Joint Radiofrequency Ablation (N-SIJRFA), Conventional Sacroiliac Joint Radiofrequency Ablation (C-SIJRFA); Procedure
Lead sponsor: University of Utah; Other
Eligibility: 18 Years to 90 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 3
States / cities: Farmington, Utah • Salt Lake City, Utah • South Jordan, Utah

Conditions: Postdural Puncture Headache
Interventions: Epidural Blood Patch, Sphenopalatine Ganglion Block; Device · Drug
Lead sponsor: Rutgers, The State University of New Jersey; Other
Eligibility: 13 Years to 92 Years
Enrollment: 8 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2020
U.S. locations: 2
States / cities: New Brunswick, New Jersey

Conditions: Cervical Pain, Cervical Facet Joint Pain
Interventions: Cervical Medial Branch Radiofrequency Ablation; Procedure
Lead sponsor: University of Utah; Other
Eligibility: 18 Years and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 3
States / cities: Farmington, Utah • Salt Lake City, Utah • South Jordan, Utah

Conditions: Healthy
Interventions: Heated Lidocaine/Tetracaine Patch, 5% Lidocaine Patch; Drug
Lead sponsor: CRI Lifetree; Other
Eligibility: 18 Years to 60 Years
Enrollment: 22 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Breast Cancer
Interventions: therapeutic autologous dendritic cells, aromatase inhibition therapy, cyclophosphamide, doxorubicin hydrochloride, paclitaxel, tamoxifen citrate, gene expression analysis, protein expression analysis, reverse transcriptase-polymerase chain reaction, immunoenzyme technique, immunohistochemistry staining method, laboratory biomarker analysis, adjuvant therapy, biopsy, conventional surgery, neoadjuvant therapy, radiation therapy; Biological · Drug · Genetic + 3 more
Lead sponsor: University of Nebraska; Other
Eligibility: 19 Years to 120 Years · Female only
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2010
U.S. locations: 2
States / cities: Tampa, Florida • Omaha, Nebraska

Conditions: Actinic Keratosis, Squamous Cell Carcinoma
Interventions: Superficial shave biopsy; Procedure
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years to 89 Years
Enrollment: 7 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Osteoarthritis, Knee
Interventions: Lidoderm, Placebo patch; Drug
Lead sponsor: Endo USA Inc., a Keenova Therapeutics Company; Industry
Eligibility: 18 Years and older
Enrollment: 224 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2004
U.S. locations: 24
States / cities: Birmingham, Alabama • Hueytown, Alabama • Tallassee, Alabama + 21 more

Conditions: Neuropathic Pain, Chronic Pain, Multiple Sclerosis
Interventions: Lidocaine patch 5%, Extended-release oxycodone, Placebo extended-release oxycodone pills, Placebo lidocaine patches; Drug
Lead sponsor: University of Rochester; Other
Eligibility: 18 Years and older
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2011
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Perioperative Chest Pain
Interventions: Lidoderm 5 % Topical Patch, Placebo patch; Drug
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Chronic Low Back Pain
Interventions: Lidoderm®, Placebo Topical Patch; Drug
Lead sponsor: Endo USA Inc., a Keenova Therapeutics Company; Industry
Eligibility: 18 Years and older
Enrollment: 215 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2004
U.S. locations: 18
States / cities: Birmingham, Alabama • Phoenix, Arizona • Carlsbad, California + 15 more

Search by objective public record fields.

Trigger Point Injections Versus Lidocaine Patch for Myofascial Pain in the Emergency Department

CO2 Laser vs Lidocaine for Vestibulodynia in Premenopausal Women

Lidocaine Patch 5% Versus Celecoxib 200 mg in Chronic Axial Low Back Pain

Adhesion Performance Study of Lidocaine Topical System 1.8% Compared to Lidocaine Patch 5% and Lidocaine Medicated Plaster 5% in Healthy, Adult, Human Subjects

A Study Of Lidocaine Patch 5% Alone, Gabapentin Alone, And Lidocaine Patch 5% And Gabapentin In Combination For The Relief Of Pain In Patients With Diverse Peripheral Neuropathic Pain Conditions

Frozen Shoulder and Hormone Replacement Therapy

Pilot Study of the Efficacy and Safety of Lidoderm Patch in the Treatment of Low Back Pain

Modality Choice Before and After Failure for the Treatment of Painful Diabetic Neuropathy

Post-Op Lidocaine Patch

Pharmacokinetics of Lidocaine in Healthy Adults

Commercial Lidocaine Patch as a Treatment for Ear-ringing

Adhesion Performance Study of Lidocaine Topical System 1.8% Compared to Generic Lidocaine Patch 5% in Healthy, Adult, Human Subjects

Lidocaine Patch Versus Celecoxib in Pain From Osteoarthritis of the Knee

Optimal Performance of RFA of the Nerves Supplying the Posterior Sacroiliac Joint Complex.

Conventional vs Bipolar SIJ RFA for Treatment of Sacroiliac Joint Pain

Therapeutic Epidural Patch Versus Pain Block in the Midface for Headache

Trident Multi-tined Cannula for Cervical MBRFA Compared to the Conventional Cannula

Evaluation of the Depth and Duration of Anesthesia From Heated Lidocaine/Tetracaine (Synera®) Patches Compared With 5% Lidocaine (Lidoderm®) Patches Applied to Healthy Adult Volunteers

Paclitaxel, Cyclophosphamide & Doxorubicin, Autologous Dendritic Cells & Surgery in Stage II/III Breast Cancer (Women)

Nanocytology Test to Evaluate Skin Cancer in High Risk Patients

Pilot Study of Lidocaine 5% Patch Versus Placebo in Patients With Osteoarthritis Pain of the Knee

Trial of Analgesia With Lidocaine or Extended-release Oxycodone for Neuropathic Pain Treatment in Multiple Sclerosis

Lidocaine 5% Patch (Lidoderm) for the Prevention of Acute and Chest Pain Following Robotic Valve Surgery

A Study Comparing The Efficacy And Safety Of Lidocaine 5% Patch With Placebo In Patients With Chronic Axial Low Back Pain